BenzingaSeptember 18, 2026 at 4:56 AM NYLast Month
Oppenheimer Maintains Outperform on Amrize, Lowers Price Target to $55
Oppenheimer analyst Bryan Blair maintains Amrize (NYSE:AMRZ) with a Outperform and lowers the price target from $62 to $55.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
